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remains to be defined. Epithelial-to-mesenchymal transition
(EMT) has emerged as a critical step in the conversion of early
stage to aggressive cancer. Employing our previously established
stable human cancer cell lines {prostate (LNCaP), breast (MCF-7)
and fibrosarcoma (HT1080) cells} over expressing MT1-MMP-GFP
(MT1-GFP) as well as GFP expressing control cells (Thromb Hae-
most 93:770–8; 2005), we examined the role of MT1-MMP in pro-
moting EMT. Expression of MT1-MMP in all three cell lines
promoted cell proliferation in 3 dimensional (3D) cultures, but
not in 2D cultures. Enzymatic activity of MT1-MMP is required
for enhanced cell proliferation suggesting that cellular degrada-
tion of surrounding collagen is a prerequisite. GFP-expressing
control LNCaP and MCF-7 cells cultivated in 3D type I collagen
gels gradually formed spherical aggregates, whereas cells
expressing MT1-GFP displayed a scattered growth pattern.
MT1-MMP-induced cell scattering was abrogated by targeted
inhibition of either the catalytic domain (TIMP-2) or the hemo-
pexin domain (recombinant PEX) domain of MT1-MMP, indicat-
ing a specific role for each domain in cell scattering. Abrogation
of MT1-MMP-induced phenotypic changes (fibroblast-like mor-
phology and cell scattering) was reversible upon withdrawal of
inhibitors. MT1-MMP transfected LNCaP and MCF-7 cells also
degraded the cell–cell adherins junction molecule, E-cadherin.
In contrast to epithelial carcinoma (LNCaP, MCF-7), non trans-
fected HT1080 cells, which are mesenchymal in origin, dis-
played a scattered growth pattern in 3D collagen gels.
Transfection of HT1080 cells with MT1-MMP or treatment with
high dose TIMP-2, did not alter the scattered growth pattern
of HT1080 cells. These results are consistent with experiments
demonstrating that mesenchymal-amoeboid cell invasion is
independent of MMP activity (Wolf, K., et al. J. Cell Biol. 160:
267–77; 2003). We hypothesize that MT1-MMP degradation of
E-cadherin and collagen induce signal transduction pathways
leading to mesenchymal-associated morphologic changes and
promoting cancer cell migration and proliferation in 3D colla-
gen gels, thus recapitulating EMT. The central role of MT1-
MMP in epithelial cancer progression provides a stimulus for
development of specific inhibitors as treatment of early stage
cancer.
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Five to ten percent of all breast carcinomas originate from a
hereditary predisposition. Some of them have been associated
to mutations in the BRCA1 and BRCA2 susceptibility genes.
However, a large number of hereditary breast cancer cases are
not accounted by mutations in these two genes and are
believed to be due to as yet unidentified breast cancer predispo-
sition genes (BRCAX). Despite intensive effort, their identifica-
tion has been so far unsuccessful, presumably because of
genetic heterogeneity, low penetrance, or recessive/polygenic
mechanisms.
We have performed a comprehensive transcriptional profiling
analysis on a group of tumor specimens from BRCA patients with
the aim to find if the different genetic condition can distinguish
BRCA1, BRCA2 and BRCAX cases and is able to explain the heter-
ogeneity of BRCAX families. Moreover, we have integrated mRNA
and MiRNA analyses on the same cases to identify MiRNA depen-
dent mechanisms involved in hereditary breast cancer. We have
analyzed 50 familial breast cancer cases consisting in 18 samples
from patients characterized by carrying germ-line mutations of
BRCA1 gene, 11 samples with BRCA2 mutations and 20 samples
from BRCAX patients, respectively. As a control, 13 tumors from
patients with no family history of breast cancer were similarly
analyzed.
Since microarray studies showed that the main clusteriza-
tion in terms of gene expression profiles of breast cancers fol-
lows the status ER+ (estrogen receptor positive) and
ER (estrogen receptor negative), we applied a linear model that
adjusted for ER status the sample analysis. After the adjust-
ment, class comparison studies show that only BRCA1 samples
exhibited a significant number of differentially expressed genes
compared to any of the other hereditary or non-hereditary
groups of samples.
Interestingly, BRCAX cases cluster into two distinct sub-
groups, one mixed up to BRCA2 and sporadic cases, the other clo-
ser to BRCA1 samples, and containing only BRCAX cases. The dis-
tinct biological identity of the two sub-groups is further
supported by the fact that the same bipartition occurs when we
used the 6 genes common between our and Hedenfalk et al.’s
(PNAS, 100: 2532–7; 2003) classifier which defines BRCAX sub-
groups. Clinical characteristics of the tumors show that those
belonging to the group containing only BRCAX cases are similar
to BRCA1 tumors. Samples mixed to BRCA2 and sporadic cases
are more heterogeneous, suggesting a possible involvement of
low penetrance genes.
Analysis of the same cases by miRNA expression profile on an
array containing 245 miRNA from human and mouse genome
highlighted that miRNA deregulation is a frequent event in spo-
radic breast cancer and distinguishes it from the heredo-familial
cases. It is also worth noting that MiRNA analysis confirmed the
existence of the two BRCAX sub-groups.
We are now integrating gene expression and miRNA data to
identify the targets of the miRNAs found as differentially
expressed in the groups in analysis.
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DNA array technology holds great promises for the improvement
of diagnostic procedures in many medical fields. We demon-
strate that expression profiling analyses of FNAB samples using
8 E J C S U P P L E M E N T S 4 ( 2 0 0 6 ) 3 –2 6
